Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer (mCRC): A preplanned analysis of the phase III AXEPT trial

被引：0

作者：

Xu, R. ^{[1
]}

Muro, K. ^{[2
]}

Kim, T. W. ^{[3
]}

Park, Y. S. ^{[4
]}

Wang, W. ^{[5
]}

Han, S-W. ^{[6
]}

Kotaka, M. ^{[7
]}

Deng, Y-H. ^{[8
]}

Ahn, J. B. ^{[9
]}

Nakamura, M. ^{[10
]}

Ba, Y. ^{[11
]}

Cho, S-H. ^{[12
]}

Kato, T. ^{[13
]}

Zhang, T. ^{[14
]}

Lee, K-W. ^{[15
]}

Matsuoka, H. ^{[16
]}

Fang, W-J. ^{[17
]}

Morita, S. ^{[18
]}

Iwasa, S. ^{[19
]}

Junichi, S. ^{[20
]}

机构：

[1] Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, Guangzhou, Guangdong, Peoples R China

[2] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan

[3] Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea

[4] Samsung Med Ctr, Dept Med, Seoul, South Korea

[5] First Peoples Hosp Foshan, Dept Gastrointestinal Oncol, Foshan, Peoples R China

[6] Seoul Natl Univ Hosp, Internal Med, Seoul, South Korea

[7] Sano Hosp, Gastrointestinal Canc Ctr, Surg, Kobe, Hyogo, Japan

[8] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China

[9] Yonsei Univ, Severance Hosp, Dept Internal Med, Seoul, South Korea

[10] Aizawa Hosp, Aizawa Comprehens Canc Ctr, Matsumoto, Nagano, Japan

[11] Tianjin Med Univ, Canc Inst & Hosp, Dept Digest Oncol, Tianjin, Peoples R China

[12] Chonnam Natl Univ Hosp, Hematol Oncol, Gwanju, South Korea

[13] Natl Hosp Org Osaka Natl Hosp, Colorectal Surg, Osaka, Japan

[14] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Abdominal Oncol, Wuhan, Hubei, Peoples R China

[15] Seoul Natl Univ, Bundang Hosp, Coll Med, Internal Med, Seongnam, South Korea

[16] Fujita Hlth Univ Hosp, Surg, Toyoake, Aichi, Japan

[17] Zhejiang Univ, Affiliated Hosp 1, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China

[18] Kyoto Univ, Med Stat & Bioinformat, Kyoto, Japan

[19] Natl Canc Ctr, Dept Expt Therapeut, Tokyo, Japan

[20] Tokai Cent Hosp, Kakamigahara, Japan

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

88O

引用

页数：2

共 50 条

[1] Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer
Iwasa, Satoru
Muro, Kei
Morita, Satoshi
Park, Young Suk
Nakamura, Masato
Kotaka, Masahito
Nishina, Tomohiro
Matsuoka, Hiroshi
Ahn, Joong Bae
Lee, Keun-Wook
Hong, Yong Sang
Han, Sae Won
Cho, Sang-Hee
Zhang, Dong-Sheng
Fang, Wei-Jia
Bai, Li
Yuan, Xiang-Lin
Yuan, Ying
Yamada, Yasuhide
Sakamoto, Junichi
Kim, Tae Won
CANCER SCIENCE, 2021, 112 (11) : 4669 - 4678
[2] UGT1A1 gene polymorphism: Impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer
Schulz, Christoph
Heinemann, Volker
Schalhorn, Andreas
Moosmann, Nikolas
Zwingers, Thomas
Boeck, Stefan
Giessen, Clemens
Stemmler, Hans-Joachim
WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (40) : 5058 - 5066
[3] UGT1A1 gene polymorphism: Impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer
Christoph Schulz
Volker Heinemann
Andreas Schalhorn
Nikolas Moosmann
Thomas Zwingers
Stefan Boeck
Clemens Giessen
Hans-Joachim Stemmler
World Journal of Gastroenterology, 2009, 15 (40) : 5058 - 5066
[4] Impact of UGT1A1 genotype and irinotecan exposure on outcomes in Japanese patients with advanced colorectal cancer treated by irinotecan-based regimens
Ichikawa, W.
Uehara, K.
Minamimura, K.
Tanaka, C.
Sadahiro, S.
Shinozaki, K.
Fukumoto, K.
Takii, Y.
Otsuji, T.
Kambara, T.
Gamoh, M.
Morita, S.
Ando, Y.
Arai, M.
Sugihara, M.
Sugiyama, T.
Ohashi, Y.
Sakata, Y.
EUROPEAN JOURNAL OF CANCER, 2015, 51 : S362 - S362
[5] Impact of UGT1A1 genotype on prognosis in Japanese advanced colorectal cancer patients treated by irinotecan-based regimens.
Ichikawa, Wataru
Uehara, Keisuke
Minamimura, Keisuke
Tanaka, Chihiro
Takii, Yasumasa
Miyauchi, Hideaki
Sadahiro, Sotaro
Shinozaki, Katsunori
Fukumoto, Kanehisa
Otsuji, Toshio
Kambara, Takeshi
Morita, Satoshi
Ando, Yuichi
Okutani, Yukihiro
Sugihara, Masahiro
Sugiyama, Toru
Ohashi, Yasuo
Sakata, Yuh
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[6] UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer
Xu, Chunlei
Tang, Xushan
Qu, Yanli
Keyoumu, Saifuding
Zhou, Ning
Tang, Yong
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (01) : 119 - 130
[7] The efficacy and safety of FOLFIRI plus BEV/mXELIRI+BEV by UGT1A1 polymorphisms in metastatic colorectal cancer AXEPT trial
Matsuoka, Hiroshi
Kagawa, Yoshinori
Ota, Mitsuyoshi
Makiyama, Akitaka
Akiyoshi, Kohei
Denda, Tadamichi
Matsuda, Chu
Yamada, Yasuhide
Morita, Satoshi
Sakamoto, Junichi
Muro, Kei
Nakamura, Masato
Kotaka, Masahito
Nishina, Tmohiro
Yabuno, Taichi
Matsui, Takanori
Iwasa, Satoru
Kim, Tae Won
Xu, Rui-Hua
Park, Young Suk
ANNALS OF ONCOLOGY, 2019, 30
[8] UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer
Chunlei Xu
Xushan Tang
Yanli Qu
Saifuding Keyoumu
Ning Zhou
Yong Tang
Cancer Chemotherapy and Pharmacology, 2016, 78 : 119 - 130
[9] A multicenter exploratory study of irinotecan-based chemotherapy on UGT1A1 polymorphisms for patients with colorectal cancer.
Chikakiyo, Motoya
Sato, Hirohiko
Kurita, Nobuhiro
Iwata, Takashi
Yoshikawa, Kozo
Kashihara, Hideya
Mikami, Chie
Matsumoto, Noriko
Eto, Shohei
Shimada, Mitsuo
Hotchi, Masanori
Okitsu, Hiroshi
Sonaka, Yasuhide
Yoshida, Sadahiro
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
[10] Clinical significance of UGT1A1 gene polymorphisms on irinotecan-based regimens as the treatment in metastatic colorectal cancer
Li, Minmin
Wang, Zhehai
Guo, Jun
Liu, Jie
Li, Changzheng
Liu, Lin
Shi, Huan
Liu, Liyan
Li, Huihui
Xie, Chao
Zhang, Xia
Sun, Wenwen
Fang, Shu
Bi, Xiang
ONCOTARGETS AND THERAPY, 2014, 7 : 1653 - 1661

← 1 2 3 4 5 →